[A case of colon cancer with severe anal bleeding caused in a preoperative chemotherapy].
UFT was orally administered at a dose of 600 mg/day as a preoperative chemotherapy for a 44-year old male with colon cancer. On the seventh day of the administration, severe anal bleeding occurred, and an emergent colectomy was performed. The macroscopic findings of the resected tumor were different from the first endoscopic picture, and the histopathological findings showed the significant effects of preoperative chemotherapy.
Fujii
M
M
3rd Dept. of Surgery, Nihon University School of Medicine, Tokyo, Japan.
Wakabayashi
K
K
Kochi
M
M
Konomi
K
K
Yamagata
M
M
Iwai
S
S
Tanaka
T
T
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000284:Administration, Oral; D000328:Adult; D001003:Anal Canal; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003106:Colon / Q000473:pathology; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006471:Gastrointestinal Hemorrhage / Q000209:etiology*; D006801:Humans; D008297:Male; D009336:Necrosis; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D005641:Tegafur; D014498:Uracil